Metabolic Changes in Peripheral Blood Mononuclear Cells Isolated From Patients With End Stage Renal Disease
Mehmet M. Altintas(The University of Texas Medical Branch at Galveston), Haimanot Wasse(Rush University Medical Center)
Cited by 30
Related Papers
Soluble Urokinase Receptor and Chronic Kidney Disease
|New England Journal of Medicine|2015|415
A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney disease
|Nature Medicine|2017|204
Soluble Urokinase Receptor and Acute Kidney Injury
|New England Journal of Medicine|2020|204